Summit Trail Advisors LLC Makes New $281,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Summit Trail Advisors LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 473 shares of the biotechnology company’s stock, valued at approximately $281,000.

A number of other hedge funds have also recently modified their holdings of the business. FSR Wealth Management Ltd. bought a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $238,000. Comprehensive Financial Planning Inc. PA purchased a new stake in Axon Enterprise in the fourth quarter worth $150,000. Savant Capital LLC lifted its position in shares of Axon Enterprise by 5.7% during the fourth quarter. Savant Capital LLC now owns 1,080 shares of the biotechnology company’s stock worth $642,000 after purchasing an additional 58 shares during the last quarter. Burns Matteson Capital Management LLC boosted its stake in shares of Axon Enterprise by 3.4% during the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock valued at $450,000 after purchasing an additional 25 shares during the period. Finally, Kestra Private Wealth Services LLC grew its holdings in shares of Axon Enterprise by 44.6% in the fourth quarter. Kestra Private Wealth Services LLC now owns 14,420 shares of the biotechnology company’s stock worth $8,570,000 after purchasing an additional 4,449 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $665.08 on Thursday. Axon Enterprise, Inc. has a 12-month low of $255.68 and a 12-month high of $698.67. The business’s fifty day simple moving average is $623.80 and its 200-day simple moving average is $502.57. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market cap of $50.71 billion, a PE ratio of 171.86, a PEG ratio of 6.79 and a beta of 1.05.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on AXON shares. JMP Securities lifted their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a report on Tuesday, February 4th. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Needham & Company LLC increased their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Finally, TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $542.15.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock worth $5,631,561 in the last ninety days. 6.10% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.